Why is Maitreya falling/rising?

As of 20-Jun, Maitreya Medicare Ltd is currently priced at 279.45, reflecting an increase of 5.95 or 2.18%. Despite this positive movement today, the stock has underperformed in the short term, with a 1-week decline of 2.94% and a 1-month decrease of 0.27%. The stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. However, there has been a rise in investor participation, with delivery volume increasing by 20% compared to the 5-day average. While the stock has generated a remarkable return of 110.11% over the past year, it has faced significant challenges, including a 40% drop in profits and a negative PAT for the latest quarter.
In the broader market context, Maitreya's recent performance contrasts with the benchmark Sensex, which has gained 1.59% over the past week and 1.74% over the past month. The stock's long-term fundamental strength appears weak, as it has not declared results in the last six months, and its operating profit to net sales is at a low of -7.74%. This lack of financial clarity, combined with declining profits, raises concerns among investors, despite the stock's impressive annual return compared to the market's modest gains.